Q1 2010

Source filing unavailable

Q1 2010 · —

Revenue

$454.20M

no prior Q1 2009 on file

Net Income

$34.90M

no prior Q1 2009 on file

EPS Diluted

$1.24

no prior Q1 2009 on file

Gross Profit$257,100,000—

Operating Income$63,247,000—

Operating Cash Flow$22,269,000

Same quarter

no prior Q1 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR